Subcutaneous patient-controlled analgesia with hydromorphone for the treatment of refractory cancer pain in older hospitalized patients: a retrospective real-world study
Hong Yang, Yiming Shen, Mengting Chen, Junhui Zhang, Lei Lei, Huiqing Yu · 2026
Read Subcutaneous patient-controlled analgesia with hydromorphone for the treatment of refractory cancer pain in older hospitalized patients: a retrospective real-world study by Hong Yang, Yiming Shen, Mengting Chen, Junhui Zhang, Lei Lei, Huiqing Yu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13286818.txt.
Description
Hong Yang and colleagues review a patient-controlled pain pump strategy for older hospital patients whose cancer pain resisted standard opioids. The 2026 study covers 499 patients treated during 2024 in a geriatric oncology ward. The pump delivers hydromorphone under the skin, letting patients trigger doses when pain spikes, which suits those who cannot swallow pills reliably.
Average pain scores fell by more than two points within a day, a drop considered clinically meaningful, and satisfactory relief arrived in about forty minutes for the typical patient. Roughly half the patients improved by at least half. Recorded side effects were rare, and none involved slowed breathing. The authors support the approach for selected patients while asking for prospective comparisons.
Catalog record
| CREATOR | Hong Yang, Yiming Shen, Mengting Chen, Junhui Zhang, Lei Lei, Huiqing Yu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |